KD Logo

Blueprint Medicines Corp [BPMC] Insider Activity: An Update for Investors

Blueprint Medicines Corp’s recent filing unveils that its CHIEF FINANCIAL OFFICER Landsittel Michael unloaded Company’s shares for reported $1.05 million on May 02 ’24. In the deal valued at $105.00 per share,10,000 shares were sold. As a result of this transaction, Landsittel Michael now holds 47,286 shares worth roughly $4.99 million.

Then, Hurley Ariel sold 1,834 shares, generating $190,516 in total proceeds. Upon selling the shares at $103.88, the PRINCIPAL ACCOUNTING OFFICER now owns 14,913 shares.

Before that, Landsittel Michael sold 5,000 shares. Blueprint Medicines Corp shares valued at $475,000 were divested by the CHIEF FINANCIAL OFFICER at a price of $95.00 per share. As a result of the transaction, Landsittel Michael now holds 47,286 shares, worth roughly $4.99 million.

Stephens initiated its Blueprint Medicines Corp [BPMC] rating to an Overweight in a research note published on May 14, 2024; the price target was $140. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early May from “an Underperform” to “a Market perform”. Oppenheimer also remained covering BPMC and has increased its forecast on October 27, 2023 with a “an Outperform” recommendation from previously “Perform” rating. Needham maintained its rating on August 21, 2023. It rated BPMC as “a Buy”.

Price Performance Review of BPMC

On Tuesday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock fall -2.40% to $105.46. Over the last five days, the stock has lost -2.85%. Blueprint Medicines Corp shares have risen nearly 14.33% since the year began. Nevertheless, the stocks have risen 95.22% over the past one year. While a 52-week high of $110.93 was reached on 05/14/24, a 52-week low of $43.89 was recorded on 02/14/24. SMA at 50 days reached $93.52, while 200 days put it at $73.06. A total of 0.58 million shares were traded, compared to the trading of 0.38 million shares in the previous session.

Levels Of Support And Resistance For BPMC Stock

The 24-hour chart illustrates a support level at 103.48, which if violated will result in even more drops to 101.49. On the upside, there is a resistance level at 109.23. A further resistance level may holdings at 113.00. The Relative Strength Index (RSI) on the 14-day chart is 62.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.64, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.65%. Stochastics %K at 81.24% indicates the stock is a selling.

Most Popular

[the_ad id="945"]